Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)
HKD 1.3
(-2.99%)
HKD 1.3
(-2.99%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.46 Billion CNY | -7.25% |
| 2022 | 1.57 Billion CNY | -8.55% |
| 2021 | 1.72 Billion CNY | -7.79% |
| 2020 | 1.86 Billion CNY | 413.96% |
| 2019 | 363.32 Million CNY | -23.28% |
| 2018 | 473.59 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.31 Billion CNY | -10.11% |
| 2024 Q2 | 1.31 Billion CNY | 0.0% |
| 2023 Q1 | 1.59 Billion CNY | 1.29% |
| 2023 FY | 1.46 Billion CNY | -7.25% |
| 2023 Q4 | 1.46 Billion CNY | 0.0% |
| 2023 Q3 | 1.46 Billion CNY | -8.43% |
| 2023 Q2 | 1.59 Billion CNY | 0.0% |
| 2022 Q3 | 1.57 Billion CNY | -1.67% |
| 2022 Q2 | 1.6 Billion CNY | 0.0% |
| 2022 Q1 | 1.6 Billion CNY | -7.0% |
| 2022 FY | 1.57 Billion CNY | -8.55% |
| 2022 Q4 | 1.57 Billion CNY | 0.0% |
| 2021 Q3 | 1.72 Billion CNY | -8.06% |
| 2021 Q4 | 1.72 Billion CNY | 0.0% |
| 2021 Q1 | 1.87 Billion CNY | 0.29% |
| 2021 FY | 1.72 Billion CNY | -7.79% |
| 2021 Q2 | 1.87 Billion CNY | 0.0% |
| 2020 FY | 1.86 Billion CNY | 413.96% |
| 2020 Q4 | 1.86 Billion CNY | 0.0% |
| 2020 Q3 | 1.86 Billion CNY | 309.76% |
| 2020 Q2 | 455.72 Million CNY | 0.0% |
| 2020 Q1 | 455.72 Million CNY | 25.43% |
| 2019 FY | 363.32 Million CNY | -23.28% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q3 | 363.32 Million CNY | 0.0% |
| 2019 Q4 | 363.32 Million CNY | 0.0% |
| 2018 FY | 473.59 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -256.222% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 87.015% |